IBB holdings: all 245 positions
IBB held 245 positions as of Oct 13, 2026. Gilead Sciences is the largest at 8.44%; the top 10 are 50.6% of the fund.
Every position
| # | Holding | Ticker | Weight ↓ |
|---|---|---|---|
| 1 | Gilead Sciences | GILD | 8.44% |
| 2 | Amgen Inc | AMGN | 8.01% |
| 3 | Vertex Pharmaceuticals | VRTX | 7.44% |
| 4 | Moderna | MRNA | 5.83% |
| 5 | Regeneron Pharmaceuticals | REGN | 5.51% |
| 6 | Natera | NTRA | 3.93% |
| 7 | Argenx SE ADR | ARGX | 3.29% |
| 8 | Illumina Inc | ILMN | 3.02% |
| 9 | Revolution Medicines | RVMD | 2.68% |
| 10 | Biogen | BIIB | 2.48% |
| 11 | Alnylam Pharmaceuticals | ALNY | 2.21% |
| 12 | Beone Medicines AG | ONC | 2.17% |
| 13 | United Therapeutics | UTHR | 1.66% |
| 14 | Incyte Corp | INCY | 1.61% |
| 15 | Insmed | INSM | 1.54% |
| 16 | Genmab Sponsored ADR | GMAB | 1.50% |
| 17 | Roivant Sciences Ltd | ROIV | 1.29% |
| 18 | Exelixis Inc | EXEL | 1.05% |
| 19 | Charles River Laboratories Interna | CRL | 1.04% |
| 20 | Ascendis Pharma | ASND | 1.02% |
| 21 | Medpace Holdings | MEDP | 1.01% |
| 22 | Neurocrine Biosciences | NBIX | 1.00% |
| 23 | Halozyme Therapeutics | HALO | 0.91% |
| 24 | BIO Techne | TECH | 0.84% |
| 25 | Bridgebio Pharma | BBIO | 0.82% |
| 26 | Biomarin Pharmaceutical | BMRN | 0.77% |
| 27 | Madrigal Pharmaceuticals | MDGL | 0.72% |
| 28 | Vaxcyte | PCVX | 0.72% |
| 29 | Twist Bioscience | TWST | 0.71% |
| 30 | Repligen | RGEN | 0.69% |
| 31 | Biontech SE ADR | BNTX | 0.63% |
| 32 | Protagonist Therapeutics | PTGX | 0.63% |
| 33 | 10X Genomics Class A | TXG | 0.61% |
| 34 | Krystal Biotech | KRYS | 0.61% |
| 35 | Cytokinetics | CYTK | 0.61% |
| 36 | Kymera Therapeutics | KYMR | 0.59% |
| 37 | Arrowhead Pharmaceuticals | ARWR | 0.57% |
| 38 | Tempus Ai Class A | TEM | 0.54% |
| 39 | Ionis Pharmaceuticals | IONS | 0.51% |
| 40 | Axsome Therapeutics | AXSM | 0.51% |
| 41 | Alkermes | ALKS | 0.48% |
| 42 | Praxis Precision Medicines | PRAX | 0.47% |
| 43 | Spyre Therapeutics Inc | SYRE | 0.47% |
| 44 | Abivax American Depositary Shares | ABVX | 0.46% |
| 45 | Bruker | BRKR | 0.46% |
| 46 | Grail Inc | GRAL | 0.44% |
| 47 | Rhythm Pharmaceuticals | RYTM | 0.42% |
| 48 | Iovance Biotherapeutics Inc | IOVA | 0.42% |
| 49 | Kodiak Sciences | KOD | 0.39% |
| 50 | PTC Therapeutics | PTCT | 0.35% |
| 51 | Travere Therapeutics | TVTX | 0.35% |
| 52 | Oruka Therapeutics Inc | ORKA | 0.34% |
| 53 | Crispr Therapeutics AG | CRSP | 0.33% |
| 54 | Definium Therapeutics Inc | DFTX | 0.33% |
| 55 | Cogent Biosciences | COGT | 0.32% |
| 56 | Mirum Pharmaceuticals | MIRM | 0.31% |
| 57 | Scholar Rock Holding | SRRK | 0.30% |
| 58 | Adaptive Biotechnologies | ADPT | 0.29% |
| 59 | Immunitybio | IBRX | 0.28% |
| 60 | Caris Life Sciences | CAI | 0.28% |
| 61 | CG Oncology | CGON | 0.27% |
| 62 | Erasca | ERAS | 0.27% |
| 63 | Veracyte | VCYT | 0.25% |
| 64 | Acadia Pharmaceuticals | ACAD | 0.23% |
| 65 | Xenon Pharmaceuticals | XENE | 0.23% |
| 66 | Abcellera Biologics | ABCL | 0.23% |
| 67 | Ideaya Biosciences | IDYA | 0.23% |
| 68 | Tango Therapeutics | TNGX | 0.23% |
| 69 | Caredx | CDNA | 0.23% |
| 70 | Relay Therapeutics | RLAY | 0.22% |
| 71 | Edgewise Therapeutics | EWTX | 0.22% |
| 72 | Legend Biotech ADR Rep | LEGN | 0.22% |
| 73 | Tarsus Pharmaceuticals | TARS | 0.22% |
| 74 | Arcutis Biotherapeutics | ARQT | 0.21% |
| 75 | Amylyx Pharmaceuticals | AMLX | 0.21% |
| 76 | Denali Therapeutics | DNLI | 0.20% |
| 77 | Immunovant | IMVT | 0.18% |
| 78 | Enliven Therapeutics | ELVN | 0.18% |
| 79 | Summit Therapeutics | SMMT | 0.17% |
| 80 | Dyne Therapeutics | DYN | 0.17% |
| 81 | Beam Therapeutics | BEAM | 0.17% |
| 82 | Adma Biologics | ADMA | 0.16% |
| 83 | ZAI Laboratory ADR Representing Lt | ZLAB | 0.16% |
| 84 | Nurix Therapeutics | NRIX | 0.16% |
| 85 | Vericel | VCEL | 0.15% |
| 86 | Novavax | NVAX | 0.15% |
| 87 | Fortrea Holdings Inc | FTRE | 0.15% |
| 88 | Aurinia Pharmaceuticals | AUPH | 0.14% |
| 89 | Arcus Biosciences | RCUS | 0.14% |
| 90 | Recursion Pharmaceuticals Class A | RXRX | 0.14% |
| 91 | Biocryst Pharmaceuticals | BCRX | 0.13% |
| 92 | Agios Pharmaceuticals | AGIO | 0.13% |
| 93 | Zymeworks | ZYME | 0.13% |
| 94 | Sarepta Therapeutics | SRPT | 0.12% |
| 95 | Grifols ADR Representing One Non-V | GRFS | 0.12% |
| 96 | Xencor | XNCR | 0.12% |
| 97 | Disc Medicine | IRON | 0.12% |
| 98 | Intellia Therapeutics | NTLA | 0.12% |
| 99 | Urogen Pharma | URGN | 0.12% |
| 100 | Vera Therapeutics Class A | VERA | 0.12% |
| 101 | Newamsterdam Pharma | NAMS | 0.12% |
| 102 | Novocure | NVCR | 0.11% |
| 103 | MBX Biosciences | MBX | 0.11% |
| 104 | Biohaven | BHVN | 0.11% |
| 105 | VIR Biotechnology | VIR | 0.10% |
| 106 | Structure Therapeutics ADR | GPCR | 0.10% |
| 107 | Uniqure | QURE | 0.10% |
| 108 | Absci Corp | ABSI | 0.10% |
| 109 | Ultragenyx Pharmaceutical | RARE | 0.10% |
| 110 | Mineralys Therapeutics | MLYS | 0.09% |
| 111 | Compass Pathways ADR PLC | CMPS | 0.09% |
| 112 | Lakefront Biotherapeutics ADR NV | LKFT | 0.09% |
| 113 | Immunocore Holdings ADR PLC | IMCR | 0.09% |
| 114 | Anaptysbio | ANAB | 0.09% |
| 115 | Precigen | PGEN | 0.09% |
| 116 | Stoke Therapeutics | STOK | 0.09% |
| 117 | Nuvation Bio Class A | NUVB | 0.09% |
| 118 | Trevi Therapeutics | TRVI | 0.09% |
| 119 | Personalis | PSNL | 0.08% |
| 120 | Syndax Pharmaceuticals | SNDX | 0.08% |
| 121 | Septerna | SEPN | 0.08% |
| 122 | Replimune Group | REPL | 0.08% |
| 123 | Mesoblast ADR Representing | MESO | 0.08% |
| 124 | Janux Therapeutics | JANX | 0.07% |
| 125 | Pharvaris N V | PHVS | 0.07% |
| 126 | Castle Biosciences | CSTL | 0.07% |
| 127 | Tyra Biosciences | TYRA | 0.07% |
| 128 | GH Research PLC | GHRS | 0.07% |
| 129 | Stevanato Group | STVN | 0.07% |
| 130 | Inhibrx Biosciences Inc | INBX | 0.07% |
| 131 | Taysha Gene Therapies | TSHA | 0.07% |
| 132 | Mannkind | MNKD | 0.07% |
| 133 | Alvotech SA | ALVO | 0.07% |
| 134 | Maze Therapeutics | MAZE | 0.07% |
| 135 | Zenas Biopharma | ZBIO | 0.06% |
| 136 | Rigel Pharmaceuticals | RIGL | 0.06% |
| 137 | Kura Oncology | KURA | 0.06% |
| 138 | Rapport Therapeutics | RAPP | 0.06% |
| 139 | Alto Neuroscience Inc | ANRO | 0.06% |
| 140 | Oric Pharmaceuticals | ORIC | 0.06% |
| 141 | Geron | GERN | 0.06% |
| 142 | Bicara Therapeutics Inc | BCAX | 0.06% |
| 143 | Maravai Lifesciences Holdings Inc | MRVI | 0.05% |
| 144 | Meiragtx Holdings PLC | MGTX | 0.05% |
| 145 | Cullinan Therapeutics | CGEM | 0.05% |
| 146 | Arbutus Biopharma Corp | ABUS | 0.05% |
| 147 | Cytek Biosciences | CTKB | 0.05% |
| 148 | Alumis | ALMS | 0.05% |
| 149 | Annexon | ANNX | 0.05% |
| 150 | 4D Molecular Therapeutics Inc | FDMT | 0.05% |
| 151 | Zevra Therapeutics Inc | ZVRA | 0.05% |
| 152 | Corvus Pharmaceuticals | CRVS | 0.04% |
| 153 | Pacific Biosciences of California | PACB | 0.04% |
| 154 | Monte Rosa Therapeutics | GLUE | 0.04% |
| 155 | Ironwood Pharma Class A | IRWD | 0.04% |
| 156 | Ginkgo Bioworks Holdings Class A | DNA | 0.04% |
| 157 | Omniab Inc | OABI | 0.04% |
| 158 | Candel Therapeutics Inc | CADL | 0.04% |
| 159 | Arrivent Biopharma | AVBP | 0.04% |
| 160 | Wave Life Sciences Inc | WVE | 0.04% |
| 161 | Solid Biosciences Inc | SLDB | 0.04% |
| 162 | Olema Pharmaceuticals | OLMA | 0.04% |
| 163 | Savara | SVRA | 0.04% |
| 164 | Opko Health | OPK | 0.04% |
| 165 | Sagimet Biosciences Series A | SGMT | 0.03% |
| 166 | Altimmune Inc | ALT | 0.03% |
| 167 | Sana Biotechnology | SANA | 0.03% |
| 168 | Regenxbio | RGNX | 0.03% |
| 169 | Cytomx Therapeutics | CTMX | 0.03% |
| 170 | Aura Biosciences | AURA | 0.03% |
| 171 | Arvinas | ARVN | 0.03% |
| 172 | Aclaris Therapeutics | ACRS | 0.03% |
| 173 | Prothena PLC | PRTA | 0.03% |
| 174 | Fulgent Genetics | FLGT | 0.03% |
| 175 | Myriad Genetics | MYGN | 0.03% |
| 176 | Phathom Pharmaceuticals | PHAT | 0.03% |
| 177 | Neurogene | NGNE | 0.03% |
| 178 | Editas Medicine | EDIT | 0.03% |
| 179 | Design Therapeutics | DSGN | 0.02% |
| 180 | Emergent Biosolutions | EBS | 0.02% |
| 181 | Silence Therapeutics ADR Represent | SLN | 0.02% |
| 182 | Arcturus Therapeutics Holdings Inc | ARCT | 0.02% |
| 183 | Atea Pharmaceuticals | AVIR | 0.02% |
| 184 | Enanta Pharmaceuticals Inc | ENTA | 0.02% |
| 185 | Prime Medicine | PRME | 0.02% |
| 186 | C4 Therapeutics | CCCC | 0.02% |
| 187 | Allogene Therapeutics | ALLO | 0.02% |
| 188 | Autolus Therapeutics ADR PLC | AUTL | 0.02% |
| 189 | Fulcrum Therapeutics | FULC | 0.02% |
| 190 | ARS Pharmaceuticals | SPRY | 0.02% |
| 191 | Contineum Therapeutics Class A | CTNM | 0.02% |
| 192 | Cabaletta Bio | CABA | 0.02% |
| 193 | Standard Biotools | LAB | 0.02% |
| 194 | Rocket Pharmaceuticals | RCKT | 0.02% |
| 195 | Vanda Pharmaceuticals Inc | VNDA | 0.02% |
| 196 | Quantum Si Inc Class A | QSI | 0.02% |
| 197 | Kyverna Therapeutics | KYTX | 0.02% |
| 198 | Immuneering Class A | IMRX | 0.02% |
| 199 | Perspective Therapeutics | CATX | 0.02% |
| 200 | Keros Therapeutics | KROS | 0.02% |
| 201 | Tectonic Therapeutic | TECX | 0.01% |
| 202 | Lexeo Therapeutics | LXEO | 0.01% |
| 203 | Bioage Labs | BIOA | 0.01% |
| 204 | Lineage Cell Therapeutics Inc | LCTX | 0.01% |
| 205 | ADC Therapeutics Ltd | ADCT | 0.01% |
| 206 | Pepgen | PEPG | 0.01% |
| 207 | AC Immune SA AG | ACIU | 0.01% |
| 208 | Bridgebio Oncology Therapeutics in | BBOT | 0.01% |
| 209 | Bicycle Therapeutics ADR PLC | BCYC | 0.01% |
| 210 | Codexis | CDXS | 0.01% |
| 211 | Anavex Life Sciences Corp | AVXL | 0.01% |
| 212 | Upstream Bio | UPB | 0.01% |
| 213 | Pyxis Oncology Inc | PYXS | 0.01% |
| 214 | Quanterix | QTRX | 0.01% |
| 215 | Sionna Therapeutics | SION | 0.01% |
| 216 | Entrada Therapeutics | TRDA | 0.01% |
| 217 | Tenaya Therapeutics | TNYA | 0.01% |
| 218 | Novabridge Biosciences ADR | NBP | 0.01% |
| 219 | Voyager Therapeutics | VYGR | 0.01% |
| 220 | Larimar Therapeutics | LRMR | 0.01% |
| 221 | Lenz Therapeutics | LENZ | 0.01% |
| 222 | Alpha Teknova | TKNO | 0.01% |
| 223 | Humacyte Inc | HUMA | 0.01% |
| 224 | Black Diamond Therapeutics Inc | BDTX | 0.01% |
| 225 | Jyong Biotech Ltd | MENS | 0.00% |
| 226 | Foghorn Therapeutics | FHTX | 0.00% |
| 227 | Lyell Immunopharma | LYEL | 0.00% |
| 228 | Gossamer Bio | GOSS | 0.00% |
| 229 | Aardvark Therapeutics | AARD | 0.00% |
| 230 | Akero Therapeutics Cvr | AKE | 0.00% |
| 231 | Caribou Biosciences | CRBU | 0.00% |
| 232 | Cellectis ADR Representing SA | CLLS | 0.00% |
| 233 | Neumora Therapeutics Inc | NMRA | 0.00% |
| 234 | Immutep ADS Representing Ltd | IMMP | 0.00% |
| 235 | Chinook Therapeutics Inc | ADRO | 0.00% |
| 236 | Arcellx Inc Cvr | 0.00% | |
| 237 | Cartesian Therapeutics Inc | 0.00% | |
| 238 | Fusion Pharmaceuticals Inc Cvr | 0.00% | |
| 239 | Third Harmonic Bio Inc | THRD | 0.00% |
| 240 | AKOUOS CVRS Prvt | 0.00% | |
| 241 | Cargo Therapeutics Inc | CRGX | 0.00% |
| 242 | OMNIAB INC $12.50 VESTING Prvt | 0.00% | |
| 243 | OMNIAB INC $15.00 VESTING Prvt | 0.00% | |
| 244 | Russell 2000 Emini Cme Dec 26 | 0.00% | |
| 245 | E-Mini Health Care Sector Dec 26 | 0.00% | |
| BLK Csh Fnd Treasury Sl Agency | 0.13% | ||
| Cash Collateral Usd Sgaft | 0.01% | ||
| USD Cash | −0.01% | ||
| Cash and other net assets | 0.06% |
The book
What this list is
How the list is built
Each weight is the share of net assets the issuer’s own daily file gives, largest first. Cash and other net assets are in their own row and are not a position. A negative weight is a short or an offsetting contract. Where a source leaves out a ticker, ETFIQ fills it from the same security in another fund’s book; names are set in title case where the source used capitals. How books are read.
Weights are as the source states them, largest first.
ETFIQ links to the documents behind every figure; a link is not an endorsement. ETFIQ is an independent publisher and makes no recommendations; every figure is calculated from published data. Standards and sources →
Cite this pageCitation, APA and Markdown
ETFIQ, Holdings of IBB, data as of Oct 13, 2026. https://etfiq.com/funds/ibb/holdings/
ETFIQ. (Oct 13, 2026). Holdings of IBB. Retrieved from https://etfiq.com/funds/ibb/holdings/
[Holdings of IBB (ETFIQ, Oct 13, 2026)](https://etfiq.com/funds/ibb/holdings/)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.